Near Real-Time Post-Marketing Surveillance: The Experience of the Vaccine Safety Datalink

被引：0
|
作者：
Yih, W. K. [1 ,2 ]
Fireman, B. [3 ]
Klein, N. [3 ]
Kulldorff, M. [1 ,2 ]
Lewis, E. [3 ]
Lieu, T. [1 ,2 ]
Weintraub, E. [4 ]
Platt, R. [1 ,2 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Harvard Pilgrim Hlth Care, Boston, MA USA
[3] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
    Greene, Sharon K.
    Kulldorff, Martin
    Lewis, Edwin M.
    Li, Rong
    Yin, Ruihua
    Weintraub, Eric S.
    Fireman, Bruce H.
    Lieu, Tracy A.
    Nordin, James D.
    Glanz, Jason M.
    Baxter, Roger
    Jacobsen, Steven J.
    Broder, Karen R.
    Lee, Grace M.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (02) : 177 - 188
  • [2] Implementing Near Real-Time Vaccine Safety Surveillance Using the Clinical Practice Research Datalink
    Leite, Andreia
    Andrews, Nick
    Thomas, Sara
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 23 - 23
  • [3] Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
    Kenigsberg, Tat'Yana A.
    Hause, Anne M.
    McNeil, Michael M.
    Nelson, Jennifer C.
    Shoup, Jo Ann
    Goddard, Kristin
    Lou, Yingbo
    Hanson, Kayla E.
    Glenn, Sungching C.
    Weintraub, Eric S.
    [J]. VACCINE, 2022, 40 (22) : 3064 - 3071
  • [4] Post-marketing safety surveillance of the rotavirus vaccine in India
    Kang, Gagandeep
    Lakhkar, Anand
    Bhamare, Chetanraj
    Dharmadhikari, Abhijeet
    Narwadkar, Jyoti
    Kanujia, Arti
    Desai, Sajjad
    Gunale, Bhagwat
    Poonawalla, Cyrus S.
    Kulkarni, Prasad S.
    [J]. VACCINE: X, 2023, 15
  • [5] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Fernanda Tavares-Da-Silva
    Olivia Mahaux
    Lionel Van Holle
    François Haguinet
    Harry Seifert
    Jens-Ulrich Stegmann
    [J]. Drug Safety, 2020, 43 : 1223 - 1234
  • [6] Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine
    Tavares-Da-Silva, Fernanda
    Co, Maribel Miranda
    Dessart, Christophe
    Herve, Caroline
    Lopez-Fauqued, Marta
    Mahaux, Olivia
    Van Holle, Lionel
    Stegmann, Jens-Ulrich
    [J]. VACCINE, 2020, 38 (18) : 3489 - 3500
  • [7] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Tavares-Da-Silva, Fernanda
    Mahaux, Olivia
    Van Holle, Lionel
    Haguinet, Francois
    Seifert, Harry
    Stegmann, Jens-Ulrich
    [J]. DRUG SAFETY, 2020, 43 (12) : 1223 - 1234
  • [8] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [9] Near real-time vaccine safety surveillance with partially accrued data
    Greene, Sharon K.
    Kulldorff, Martin
    Yin, Ruihua
    Yih, W. Katherine
    Lieu, Tracy A.
    Weintraub, Eric S.
    Lee, Grace M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (06) : 583 - 590
  • [10] WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS
    Rubin, David T.
    Modesto, Irene
    Vermeire, Severine
    Danese, Silvio
    Ng, Siew C.
    Kwok, Kenneth K.
    Koram, Nana
    Jones, Thomas V.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S36 - S36
12345